WallStreetZenWallStreetZen

NASDAQ: TVTX
Travere Therapeutics Inc Stock Ownership - Who owns Travere Therapeutics?

OverviewForecastEarningsDividendOwnership

Insider buying vs selling

Have Travere Therapeutics Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Christopher R. ClineCHIEF FINANCIAL OFFICER2024-04-1154$6.74
$363.96Sell
Eric M. DubeCHIEF EXECUTIVE OFFICER2024-02-019,106$8.53
$77.69kSell
Jula InrigCHIEF MEDICAL OFFICER2024-02-012,174$8.53
$18.55kSell
Peter HeermaCHIEF COMMERCIAL OFFICER2024-02-014,195$8.53
$35.79kSell
William E. RoteSENIOR VICE PRESIDENT RD2024-02-012,590$8.86
$22.95kSell
Elizabeth E. ReedSVP GC CORPORATE SECRETARY2024-02-012,174$8.53
$18.55kSell
William E. RoteSENIOR VICE PRESIDENT RD2024-02-012,174$8.53
$18.55kSell
Christopher R. ClineCHIEF FINANCIAL OFFICER2024-02-013,818$8.53
$32.57kSell
Elizabeth E. ReedSVP GC CORPORATE SECRETARY2024-02-012,590$8.86
$22.95kSell
Eric M. DubeCHIEF EXECUTIVE OFFICER2024-02-0110,016$8.86
$88.74kSell

1 of 3

TVTX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when TVTX insiders and whales buy or sell their stock.

TVTX Shareholders

What type of owners hold Travere Therapeutics Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Ruth Shepley64.39%49,000,000$284.20MInsider
Blackrock Inc10.40%7,917,860$45.92MInstitution
Armistice Capital LLC9.70%7,384,000$42.83MInstitution
Deep Track Capital LP9.68%7,370,000$42.75MInstitution
Vanguard Group Inc7.25%5,515,143$31.99MInstitution
State Street Corp7.03%5,352,345$31.04MInstitution
Macquarie Group Ltd6.24%4,746,776$27.53MInstitution
Morgan Stanley5.44%4,136,290$23.99MInstitution
Renaissance Technologies LLC4.05%3,081,014$17.87MInstitution
Rock Springs Capital Management LP3.64%2,771,446$16.07MInstitution

1 of 3

TVTX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TVTX59.75%40.25%Net SellingNet Selling
OCS10.87%0.00%
HUMA14.97%36.38%Net Selling
TSHA69.58%15.93%Net BuyingNet Selling
FULC64.02%35.98%Net BuyingNet Buying
View Top Biotech Stocks

Travere Therapeutics Stock Ownership FAQ

Who owns Travere Therapeutics?

Travere Therapeutics (NASDAQ: TVTX) is owned by 112.45% institutional shareholders, 75.75% Travere Therapeutics insiders, and 0.00% retail investors. Ruth Shepley is the largest individual Travere Therapeutics shareholder, owning 49.00M shares representing 64.39% of the company. Ruth Shepley's Travere Therapeutics shares are currently valued at $280.28M.

If you're new to stock investing, here's how to buy Travere Therapeutics stock.
©2024 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.